Cell and Gene Outsourcing

  1. Spray Drying Applications In The Pharmaceutical Industry 3/10/2026

    Spray drying turns liquids into uniform powders, improving stability, solubility, flowability, and bioavailability while allowing precise control of particle traits.

  2. LNP And Liposomal Center Of Excellence 3/10/2026

    A connected development pathway supports smoother scale-up and greater consistency for LNP-based therapeutics. Explore how integrated expertise across key stages helps teams accelerate progress.

  3. Transparent Pricing In Bioanalysis: A Feature, Not A Bonus 3/9/2026

    Unclear CRO pricing leaves small biotechs vulnerable to budget swings. Transparent, itemized costs cut financial risk, sharpen planning, and build trust by setting expectations from the start.

  4. How Smaller Biotechs Are Rethinking CRO Relationships Post-Pandemic 3/9/2026

    Smaller biotechs are rethinking CRO partnerships, valuing speed, scientific access, flexibility, and transparent pricing over scale — driven by pandemic lessons and a sharper focus on operational fit.

  5. 5 QMS Blind Spots You Should Know About 3/6/2026

    Companies often underestimate the complexity of standing up an eQMS. These are five of the most common issues that lead to regulatory and GMP exposure risk.

  6. Translating Stem Cell Programs To GMP 3/4/2026

    A detailed exploration of challenges in advancing stem cell programs to GMP, highlighting strategies to control variability, strengthen process design, and support reliable clinical‑stage manufacturing.

  7. 4 Steps To Process Intensification Success In Biomanufacturing 3/4/2026

    For successful process intensification (PI) adoption, consider the key steps to success, including how to commit to a long-term strategy, navigate scale-up challenges, and identify ideal use cases.

  8. The Paradigm Shift: Why Process Intensification Is Gaining Traction 3/4/2026

    While fed-batch processes have long been the biomanufacturing standard, intensified processes are offering the opportunity to increase productivity, reduce COGs, and achieve sustainability targets.

  9. Activate Process Intensification Strategies To Increase Productivity 3/4/2026

    Amid pressure to cut costs, improve sustainability, and compete with biosimilars, process intensification has emerged as a compelling option to increase yields and future-proof operations.

  10. Production Technology For Scalable High-Quality Manufacturing 3/4/2026

    A plasmid‑free AAV platform delivering higher yields, cleaner product profiles, lower costs, and scalable manufacturing from early development to commercial production across serotypes.